Uncategorized
Ocular Therapeutix reports $44.7 million net loss in 2016
Ocular Therapeutix reported a net loss of $44.7 million, or $1.80 per share, in 2016 compared with a net loss of $39.7 million, or $1.71 per share, in 2015, according to a company press release.Fourth quarter net loss equaled $12.8 million, or $0.52 per share, compared with a net loss of $10.6 million, or $0.43 per share, in the same period last year.